Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Thursday, 18 May 2017

Biosimilars Market Access in Psoriatic Arthritis 2017 - Payers are Unlikely to Implement Strong Incentives to Drive U...

 
Biosimilars Market Access in Psoriatic Arthritis 2017 - Payers are Unlikely to Implement Strong Incentives to Drive Uptake of Biosimilar Infliximab Due to Limited Use of the Drug - Research and Markets
DUBLIN, May 18, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the "Biosimilars Market Access in Psoriatic Arthritis" report to their offering. Tumor necrosis factor (TNF)-alpha inhibitors Enbrel, Humira, and Remicade have long held dominant positions in...
Read more

MolecuLight® Signs Exclusive Distribution Agreement With Global Wound Care Leader Smith & Nephew
TORONTO, May 18, 2017 /PRNewswire/ -- MolecuLight is pleased to announce the execution of an exclusive global distribution agreement with Smith & Nephew to distribute the MolecuLight  i:X™  Imaging Device product line. The distribution agreement represents an important mileston...
Read more

EY and Automation Anywhere collaborate globally in enterprise intelligent automation to help increase efficiencies and cost savings
LONDON, May 18 2017 /PRNewswire/ -- EY has announced that it is working with Automation Anywhere, a global leader in robotic process automation (RPA) and intelligent automation for enterprises, to help companies to increase efficiencies and reduce costs across back- and front-office operat...
Read more

The Lancet Publishes Phase 2 Results from Shire's Investigational Anti-MAdCAM Antibody Showing Significantly Increased Remission Rates in Patients with Moderate-to-Severe Ulcerative Colitis
DUBLIN, May 18, 2017 /PRNewswire/ -- Study met primary endpoint demonstrating significantly greater remission rates in patients receiving anti-MAdCAM antibody (SHP647) compared to placebo in three of four tested dose groups First study to investigate the potential...
Read more

Vendors in the Global Energy Management System Market Capitalising on the Adoption of Emerging Technologies Such as Mobility, Cloud, Big Data, and Analytics
VALLEY COTTAGE, New York, May 18, 2017 /PRNewswire/ -- According to the latest report published by Future Market Insights (FMI), the global energy management system (EMS) market, which is currently valued at US$ 6,340 Mn is projected to reach US$ 21,626.6 Mn by 2025-end. In terms of...
Read more

PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for Lurbinectedin Covering Australia, New Zealand and Several Asian Countries
MADRID, May 18, 2017 /PRNewswire/ -- PharmaMar (MCE: PHM) today announced an agreement with Singapore-based Specialised Therapeutics Asia Pte, Ltd (STA) to market the marine-based anti-tumour compound of the Company, lurbinectedin (PM1183) for the treatment of platinum-resistant...
Read more

Biologique Recherche and Wellness for Cancer are Bringing Face and Body Treatments to Cancer Patients and Survivors Worldwide
NEW YORK, May 18, 2017 /PRNewswire/ -- Biologique Recherche has partnered with Wellness for Cancer to adapt facial and body treatments specifically to the needs of cancer patients and those in remission. Treatments will be available in the US and France in June, with plans to expand in...
Read more